This clinical trial aims to evaluate the effectiveness of a pharmacist-led counseling and self-management application program on improving asthma management outcomes among adult patients with asthma receiving care at a Midwest chain pharmacy in Iowa, United States.
The study investigates whether integrating the pharmacist counseling with self-management theory can enhance patients' medication adherence, asthma control, inhaler technique, and overall asthma awareness. These outcomes will be assessed at both 3 and 6 months after enrollment.
Participants will be randomly assigned to one of two arms. The intervention group, which will receive a comprehensive pharmacist-led counseling program supported by a mobile application ("Don R.Ph Application").
The control group, which will receive standard pharmacy care as per usual practice.
Adult patients with asthma are 25 - 64 years of age.
Have been receiving medications from the pharmacy of either Inhaled Corticosteroids (ICS) or a fixed combination of ICS with a long-acting beta-agonist (bronchodilator) and regular patronage of the pharmacy for the previous six months.
Confirmed diagnosis from either the physician's diagnosis or the patient's self-report.
No respiratory comorbidities (i.e., COPD or lung diseases).
The adult patient with asthma aged < 25 years or > 64 years old.
The patient with one of the following - coronary heart disease, severe hypertension, severe heart failure, severe musculoskeletal disorder, mental health condition, dementia, chronic obstructive lung disease, or COVID-19.
Participating in another "Pharmacy Counseling or Education Program."
The patient does not have a smartphone (iOS or Android).